News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) Fights Claims That Ex-CEO Was Paid Too Much


11/21/2013 7:52:04 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The Bill Weldon legacy lives on, at least in court. More than a year after Weldon retired as Johnson & Johnson ceo, a simmering dispute continues in a New Jersey federal court, where a J&J shareholder has filed a so-called derivative lawsuit that claims the healthcare giant provided a “lavish” compensation package that was not in keeping with his performance and belied the storied company credo.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Pharmalot


comments powered by Disqus
Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES